Partnering

Advance the next research step with S&K Therapeutics

We welcome discussions with pharmaceutical companies, biotechnology partners and academic groups interested in immune signaling modulation and regenerative peptide therapeutics.

Areas of interest

Two scientific starting points

A collaboration can begin with a program, a mechanism or a complementary experimental capability.

Immune modulation

Innate immune signaling

Endosomal TLRs, MyD88, NLRP3 and TLR9-mediated immune activation.

Mechanistic evaluation
Disease-model research
Translational milestones

Regenerative peptides

Tissue regeneration

FAP1, VMP3, SDP-4 and SP1 programs in tissue repair research.

Wound repair
Angiogenesis
Endogenous stem cell recruitment

Collaboration pathways

Research collaboration

Address a defined biological question or experimental capability.

Co-development

Examine complementary expertise and evidence needed for later decisions.

Licensing discussion

Consider a specific program and the rights relevant to it.

Starting a discussion

Begin with non-confidential scientific context

Identify the program or research area, the evidence of interest and the scientific contribution each organization could make.

Start a partnering discussion →